Trainer Ralph Nicks dominated the two $65,000 Lasix-free races for 2-year-old fillies on Gulfstream Park's July 18 card.
A bipartisan bill introduced July 16 in the U.S. House of Representatives would see the U.S. Anti-Doping Agency create an independent organization for oversight of medication issues in horse racing.
A Salix-free race proved so popular at the entry box Wednesday that the over-subscribed field of 2-year-old fillies was split into two races for Saturday's program at Gulfstream Park.
Considering possible changes to the state's equine drug laws, New York regulators are calling together education, veterinary science, and industry experts to discuss the use of the anti-bleeding medicine furosemide.
Gulfstream Park in July plans to experiment with at least two 2-year-old races that will be written for horses that don't compete on race-day furosemide, officials said June 11.
- By Tom LaMarra
United States Rep. Paul Tonko of New York said May 29 he will introduce federal legislation that would grant the United States Anti-Doping Agency oversight of equine medication and drug testing.
Horses competing in the U.S. Triple Crown races fail to sweep the series because they are under too much pressure to perform in a short amount of time, Sheikh Hamdan told Reuters Africa in an interview published May 24.
A May 6 vote to change the recommended testing threshold for the anti-bleeding medication furosemide when it is administered 24 hours before a race triggered another debate and posed more questions.
Owner Bill Casner hasn't wavered since his 2011 decision to race his Thoroughbreds without the widely used diuretic furosemide, or Salix (Lasix).
Prominent equine veterinarian Dr. Gary T. Priest has joined the Water Hay Oats Alliance, noting that he favors therapeutic medications for horses, but agrees they should be discontinued several days before a horse races.
Mubtaahij has never raced on the anti-bleeding medication Lasix, and he will run without it in the Kentucky Derby, becoming the first horse in 10 years to do so.
Trainer Michael Dickinson explains why he has joined the ranks of WHOA members working to pass federal legislation to prohibit the use of performance-enhancing drugs in North American horse racing.
New security measures will be employed for horses participating in the $1 million Toyota Blue Grass Stakes (gr. I), Keeneland announced March 25.
The Kentucky Horse Racing Commission March 23 approved a regulation that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
New York regulators March 23 said they want to hold a forum to consider the future use of anti-bleeding medication furosemide in the state.
The Kentucky Horse Racing Commission is considering a proposal that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
Kentucky Equine Research president Joe Pagan, Ph.D., will discuss proper nutrition for horses being treated with Lasix (furosemide, formally called Salix) at a March 16 seminar in Ocala, Fla.
A provision voiding the claim of a horse placed on the veterinarian's list for bleeding was approved for a 45-day public comment period by the California Horse Racing Board, though members expressed their concerns.
Legislation governing equine medication policy is scheduled to be heard Feb. 18 by the Florida Senate Regulated Industries Committee.
Terry Finley has submitted additional information he says documents a failure by New York Thoroughbred Horsemen's Association staff to publicize its 2014 election to all potential voters.
The New York State Gaming Commission has sanctioned trainer Bill Mott for a pair of medication overages in a single horse last fall, a decision the Racing Hall of Fame conditioner is appealing.
As part of its extensive investigation into Steve Asmussen stable following allegations of horse mistreatment from an animal rights group, the KHRC compiled safety numbers in which the trainer fared well
The RMTC said Dec. 9 the Thoroughbred industry has made "major gains" this year in the number of jurisdictions operating or soon to be operating under all or part of the National Uniform Medication Program.
The board of the New York Racing Association Dec. 3 approved the racing corporation's 2015 budget, but not before a spirited debate by some board members over equine drug issues.
Gulfstream Park will begin third-party administration of race-day furosemide beginning Wednesday, Nov. 19.
The Racing Medication and Testing Consortium believes the majority of racing jurisdictions will have a substantial portion of the National Uniform Medication Program in place by year's end.
Ogden Phipps said Oct. 6 a centralized regulatory body for horse racing would facilitate changes necessary to improve the integrity of the sport in the United States, but the chances of it happening are slim to none.
Charles J. Cella, president of Oaklawn Racing & Gaming, announced Sept. 18 that the Arkansas track in 2015 will offer purse bonuses for horses that run and win without furosemide (Salix or commonly called Lasix).
Jockey Club says a recent study's findings challenge long-held opinions in North American racing, including the contention that the use of the diuretic furosemide is necessary to ensure long-term careers of horses.
A study published online this spring found no link between the vast majority of horses who suffer from exercise-induced pulmonary hemorrhage and long-term racing performance.
Unless horse racing first reaches industry consensus on medication reform, the National Thoroughbred Racing Association does not expect Congress to move forward on federal medication legislation.
A Kentucky racing official Sept. 12 said the state has been at the forefront of research into cobalt, a naturally occurring element said to have blood-doping qualities if used at high levels.
Kentucky regulators are considering allowing tracks in the state to card races that would prohibit the administration of race-day furosemide, commonly called Salix or Lasix.
The National Horsemen's Benevolent and Protective Association restated its strong support for the continued use of Lasix (furosemide, also commonly called Salix) at its summer convention Aug.15-17 in Oklahoma City.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Eliminating race-day Salix is gaining momentum. read blog
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
A new study finds no difference in the racing career longevity between horses who experience some level of exercise-induced pulmonary hemorrhage and those who never experience EIPH.
Multiple racing jurisdictions have adopted all or parts of the National Uniform Medication Program, with others expected to be on board by the end of this year.
The Jockey Club should push for more in-depth furosemide research. read blog
The Jockey Club has called on leading industry organizations to come together to conduct a Salix study that would examine the timing of administration on the medication used to prevent exercise-induced pulmonary hemorrhage.
Kentucky attorney Ned Bonnie, member of the Kentucky Horse Racing Commission, lays out his argument for joining the Water Hay Oats Alliance and for supporting federal oversight of medication use in horse racing. read blog
Alan Foreman responds to criticism that little progress has been made on medication reform.
People for the Ethical Treatment of Animals said it will "go away" if horse racing addresses its medication issues, and industry officials who have been trying to do just that suggest progress is evident but not recognized.
Kentucky horsemen March 14 were given an overview of impending equine medication changes and also provided with a few tips to avoid headaches when the new regulations take effect later in the spring.
A Jan. 30 meeting of racing stakeholders in the Mid-Atlantic and Northeast regions showed how difficult it can be to achieve uniformity, even with the best intentions or most basic of regulations.
Here's a follow-up look at racing statistics of juveniles involved in the furosemide observational study results released Dec. 16 by Breeders' Cup from this year's World Championships and two California-bred stakes.
Study finds 2-year-olds racing without race-day furosemide at 2013 Breeders' Cup World Championships at Santa Anita Park had fewer and less severe EIPH instances than juveniles who raced with the diuretic that weekend at SA.
Breeders' Cup chairman Bill Farish acknowledged the organization's board of directors has some key issues it needs to address, not the least of which is the host-site selection process.
Most Popular Stories
- One-Fifth Curlin Share Surpasses $6 Million
- Breaking Lucky Surprises in Prince of Wales
- Slideshow: 2015 Racing Hall of Fame
- American Pharoah Has Final Work for Haskell
- American Pharoah Will Dictate Race Schedule
- Frac Daddy Retired With Suspensory Strain
- CDI Plans to Demolish Calder Grandstand
- Solow Aims to Keep Win Streak Alive in Sussex
- Small Farm Yields Big Returns for Smith
- Sprint Champ, Commanding Curve Spice Stakes